Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Natural products as a rich source of tau-targeting drugs for Alzheimer's disease.

Calcul L, Zhang B, Jinwal UK, Dickey CA, Baker BJ.

Future Med Chem. 2012 Sep;4(13):1751-61. doi: 10.4155/fmc.12.124. Review.

2.

Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.

Brunden KR, Trojanowski JQ, Lee VM.

Nat Rev Drug Discov. 2009 Oct;8(10):783-93. doi: 10.1038/nrd2959. Review.

3.

Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.

Ising C, Stanley M, Holtzman DM.

Clin Pharmacol Ther. 2015 Nov;98(5):469-71. doi: 10.1002/cpt.200. Epub 2015 Sep 10. Review.

PMID:
26250900
4.

Potential therapeutic agents against Alzheimer's disease from natural sources.

Park SY.

Arch Pharm Res. 2010 Oct;33(10):1589-609. doi: 10.1007/s12272-010-1010-y. Epub 2010 Oct 30. Review.

PMID:
21052936
5.

The role of natural products in the discovery of new drug candidates for the treatment of neurodegenerative disorders II: Alzheimer's disease.

da Rocha MD, Viegas FP, Campos HC, Nicastro PC, Fossaluzza PC, Fraga CA, Barreiro EJ, Viegas C Jr.

CNS Neurol Disord Drug Targets. 2011 Mar;10(2):251-70. Review.

PMID:
20874701
6.

Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.

Brunden KR, Ballatore C, Crowe A, Smith AB 3rd, Lee VM, Trojanowski JQ.

Exp Neurol. 2010 Jun;223(2):304-10. doi: 10.1016/j.expneurol.2009.08.031. Epub 2009 Sep 8. Review.

7.

Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease.

Kalra J, Khan A.

Eur J Pharmacol. 2015 Oct 5;764:571-81. doi: 10.1016/j.ejphar.2015.07.043. Epub 2015 Jul 21. Review.

PMID:
26209363
9.

Aβ regulation-based multitarget strategy for drug discovery against Alzheimer's disease.

Guo X, Jiang W, Li C, Zhu Z, Shen X.

Rev Neurosci. 2015;26(1):13-30. doi: 10.1515/revneuro-2014-0064.

PMID:
25720054
10.

Tau therapeutics for Alzheimer's disease: the promise and the challenges.

Gold M.

J Mol Neurosci. 2002 Dec;19(3):331-4. Review.

PMID:
12540060
11.

Screening strategies to identify HSP70 modulators to treat Alzheimer's disease.

Repalli J, Meruelo D.

Drug Des Devel Ther. 2015 Jan 7;9:321-31. doi: 10.2147/DDDT.S72165. eCollection 2015. Review.

12.

Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.

Shin J.

Int J Geriatr Psychiatry. 2011 May;26(5):546-8. doi: 10.1002/gps.2543. No abstract available.

PMID:
21446001
13.

Early investigational drugs targeting tau protein for the treatment of Alzheimer's disease.

Anand K, Sabbagh M.

Expert Opin Investig Drugs. 2015;24(10):1355-60. doi: 10.1517/13543784.2015.1075002. Epub 2015 Aug 1. Review.

14.

Current strategies for the treatment of Alzheimer's disease and other tauopathies.

Dickey CA, Petrucelli L.

Expert Opin Ther Targets. 2006 Oct;10(5):665-76. Review.

PMID:
16981824
15.

Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

Ballatore C, Brunden KR, Huryn DM, Trojanowski JQ, Lee VM, Smith AB 3rd.

J Med Chem. 2012 Nov 8;55(21):8979-96. doi: 10.1021/jm301079z. Epub 2012 Sep 28. Review.

16.

Emerging drug targets for Aβ and tau in Alzheimer's disease: a systematic review.

West S, Bhugra P.

Br J Clin Pharmacol. 2015 Aug;80(2):221-34. doi: 10.1111/bcp.12621. Epub 2015 Jun 8. Review.

17.

Alzheimer's Disease and Natural Products: Future Regimens Emerging from Nature.

Islam MA, Khandker SS, Alam F, Khalil MI, Kamal MA, Gan SH.

Curr Top Med Chem. 2017;17(12):1408-1428. doi: 10.2174/1568026617666170103163054. Review.

PMID:
28049401
18.

"Clicked" sugar-curcumin conjugate: modulator of amyloid-β and tau peptide aggregation at ultralow concentrations.

Dolai S, Shi W, Corbo C, Sun C, Averick S, Obeysekera D, Farid M, Alonso A, Banerjee P, Raja K.

ACS Chem Neurosci. 2011 Dec 21;2(12):694-9. doi: 10.1021/cn200088r. Epub 2011 Oct 13.

19.

Novel drugs affecting tau behavior in the treatment of Alzheimer's disease and tauopathies.

Navarrete LP, Pérez P, Morales I, Maccioni RB.

Curr Alzheimer Res. 2011 Sep;8(6):678-85. Review.

PMID:
21605038
20.

[Present and future of the tau dementia therapy].

Takashima A.

Rinsho Shinkeigaku. 2013;53(11):1040-2. Review. Japanese.

PMID:
24291873

Supplemental Content

Support Center